Int J Thyroidol.  2023 May;16(1):51-88. 10.11106/ijt.2023.16.1.51.

2023 Revised Korean Thyroid Association Guidelines for the Diagnosis and Management of Thyroid Disease during Pregnancy and Postpartum

• Yi KH
• Ahn HY
• Kim JH
• Park SY
• Yoo WS
• Jung KY
• Lee EK
• Park YJ
• Kim SW
• Yim CH
• Chung YJ
• Kang HC
• Park DJ

• KMID: 2543008
• DOI: http://doi.org/10.11106/ijt.2023.16.1.51

Abstract

Thyroid hormone plays an important role in the process of implantation of a fertilized egg in the endometrium, as well as in the division and development of the fertilized egg. In addition, maternal thyroid hormone is essential for the formation and development of the fetal brain, nervous system, and bones. Therefore, when maternal thyroid hormone is insufficient, complications such as miscarriage, stillbirth, low birth weight and preeclampsia increase. Guidelines for the diagnosis and treatment of thyroid dysfunction during pregnancy were established and published by the American Endocrine Society, the American Thyroid Association, and the European Thyroid Society. The Korean Thyroid Society also published recommendations for diagnosis and treatment of thyroid disease during pregnancy and postpartum in 2014. However, since the revised guidelines of the American Thyroid Association were published in 2017, many studies, including large-scale randomized controlled trials, have been published in relation to thyroid and pregnancy, and the need to revise the existing recommendations has emerged in Korea. The main revisions of this recommendation are changes in the normal range of TSH during pregnancy, detailed description of treatment policies according to pregnant women’s autoantibodies and thyroid function status. Also, a description of the effect of thyroid autoantibodies on assisted reproductive procedures has been added.

Keyword

Pregnancy; Hypothyroidism; Hyperthyroidism; Thyrotoxicosis; Postpartum thyroiditis

Figure

• 

  Fig. 1 An algorithm for the treatment and monitoring of postpartum thyroiditis.

Reference

References

1. Glinoer D. 1997; The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev. 18(3):404–33. DOI: 10.1210/edrv.18.3.0300. PMID: 9183570.

2. Azizi F. 2006; Treatment of post-partum thyrotoxicosis. J Endocrinol Invest. 29(3):244–7. DOI: 10.1007/BF03345547. PMID: 16682838.

3. Stagnaro-Green A. 2004; Postpartum thyroiditis. Best Pract Res Clin Endocrinol Metab. 18(2):303–16. DOI: 10.1016/j.beem.2004.03.008. PMID: 15157842.

4. Weeke J, Dybkjaer L, Granlie K, Eskjaer Jensen S, Kjaerulff E, Laurberg P, et al. 1982; A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy. Acta Endocrinol (Copenh). 101(4):531–7. DOI: 10.1530/acta.0.1010531. PMID: 7158229.

5. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, et al. 2003; Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 13(1):3–126. DOI: 10.1089/105072503321086962. PMID: 12625976.

6. Soldin OP, Tractenberg RE, Hollowell JG, Jonklaas J, Janicic N, Soldin SJ. 2004; Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and associations across trimesters in iodine sufficiency. Thyroid. 14(12):1084–90. DOI: 10.1089/thy.2004.14.1084. PMID: 15650363. PMCID: PMC3625635.

7. Kahric-Janicic N, Soldin SJ, Soldin OP, West T, Gu J, Jonklaas J. 2007; Tandem mass spectrometry improves the accuracy of free thyroxine measurements during pregnancy. Thyroid. 17(4):303–11. DOI: 10.1089/thy.2006.0303. PMID: 17465859. PMCID: PMC3641793.

8. Sapin R, D'Herbomez M, Schlienger JL. Free thyroxine measured with equilibrium dialysis and nine immunoassays decreases in late pregnancy. Clin Lab. 2004; 50(9-10):581–4.

9. Stricker R, Echenard M, Eberhart R, Chevailler MC, Perez V, Quinn FA, et al. 2007; Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals. Eur J Endocrinol. 157(4):509–14. DOI: 10.1530/EJE-07-0249. PMID: 17893266.

10. Bocos-Terraz JP, Izquierdo-Alvarez S, Bancalero-Flores JL, Alvarez-Lahuerta R, Aznar-Sauca A, Real-Lopez E, et al. 2009; Thyroid hormones according to gestational age in pregnant Spanish women. BMC Res Notes. 2:237. DOI: 10.1186/1756-0500-2-237. PMID: 19939287. PMCID: PMC2788578.

11. Derakhshan A, Shu H, Broeren MAC, de Poortere RA, Wikstrom S, Peeters RP, et al. 2018; Reference ranges and determinants of thyroid function during early pregnancy: the SELMA study. J Clin Endocrinol Metab. 103(9):3548–56. DOI: 10.1210/jc.2018-00890. PMID: 29982605.

12. Ollero MD, Toni M, Pineda JJ, Martinez JP, Espada M, Anda E. 2019; Thyroid function reference values in healthy iodine-sufficient pregnant women and influence of thyroid nodules on thyrotropin and free thyroxine values. Thyroid. 29(3):421–9. DOI: 10.1089/thy.2018.0324. PMID: 30693851.

13. Huang C, Wu Y, Chen L, Yuan Z, Yang S, Liu C. 2021; Establishment of assay method- and trimester-specific reference intervals for thyroid hormones during pregnancy in Chengdu, China. J Clin Lab Anal. 35(5):e23763. DOI: 10.1002/jcla.23763.

14. Andersen SL, Andersen S, Carle A, Christensen PA, Handberg A, Karmisholt J, et al. 2019; Pregnancy week-specific reference ranges for thyrotropin and free thyroxine in the North Denmark region pregnancy cohort. Thyroid. 29(3):430–8. DOI: 10.1089/thy.2018.0628. PMID: 30734656.

15. Choi HW, Han YJ, Kwak DW, Park SY, Kim SH, Yoon HK, et al. 2017; Maternal thyroid function during the first trimester of pregnancy in Korean women. Int J Thyroidol. 10(1):36–41. DOI: 10.11106/ijt.2017.10.1.36.

16. Kim HJ, Cho YY, Kim SW, Kim TH, Jang HW, Lee SY, et al. 2018; Reference intervals of thyroid hormones during pregnancy in Korea, an iodine-replete area. Korean J Intern Med. 33(3):552–60. DOI: 10.3904/kjim.2016.051. PMID: 28171716. PMCID: PMC5943647.

17. Dashe JS, Casey BM, Wells CE, McIntire DD, Byrd EW, Leveno KJ, et al. 2005; Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. Obstet Gynecol. 106(4):753–7. DOI: 10.1097/01.AOG.0000175836.41390.73. PMID: 16199632.

18. Yi KH, Kim KW, Yim CH, Jung ED, Chung JH, Chung HK, et al. 2014; Guidelines for the diagnosis and management of thyroid disease during pregnancy and postpartum. Int J Thyroidol. 7(1):7–39. DOI: 10.11106/jkta.2014.7.1.7.

19. Lambert-Messerlian G, McClain M, Haddow JE, Palomaki GE, Canick JA, Cleary-Goldman J, et al. 2008; First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) research consortium study. Am J Obstet Gynecol. 199(1):62 e1-6. DOI: 10.1016/j.ajog.2007.12.003. PMID: 18585522. PMCID: PMC2529146.

20. Mannisto T, Surcel HM, Ruokonen A, Vaarasmaki M, Pouta A, Bloigu A, et al. 2011; Early pregnancy reference intervals of thyroid hormone concentrations in a thyroid antibody-negative pregnant population. Thyroid. 21(3):291–8. DOI: 10.1089/thy.2010.0337. PMID: 21254924.

21. Medici M, de Rijke YB, Peeters RP, Visser W, de Muinck Keizer-Schrama SM, Jaddoe VV, et al. 2012; Maternal early pregnancy and newborn thyroid hormone parameters: the generation R study. J Clin Endocrinol Metab. 97(2):646–52. DOI: 10.1210/jc.2011-2398. PMID: 22162477.

22. Bestwick JP, John R, Maina A, Guaraldo V, Joomun M, Wald NJ, et al. 2014; Thyroid stimulating hormone and free thyroxine in pregnancy: expressing concentrations as multiples of the median (MoMs). Clin Chim Acta. 430:33–7. DOI: 10.1016/j.cca.2013.12.030. PMID: 24380740.

23. Li C, Shan Z, Mao J, Wang W, Xie X, Zhou W, et al. 2014; Assessment of thyroid function during first-trimester pregnancy: what is the rational upper limit of serum TSH during the first trimester in Chinese pregnant women? J Clin Endocrinol Metab. 99(1):73–9. DOI: 10.1210/jc.2013-1674. PMID: 24276458.

24. Carty DM, Doogan F, Welsh P, Dominiczak AF, Delles C. 2017; Thyroid stimulating hormone (TSH) >/=2.5mU/l in early pregnancy: prevalence and subsequent outcomes. Eur J Obstet Gynecol Reprod Biol. 210:366–9. DOI: 10.1016/j.ejogrb.2017.01.048. PMID: 28153744.

25. Han SM, Han JH, Park JA, Quinn FA, Park J, Oh E. 2013; Longitudinal evaluation of thyroid autoimmunity and function in pregnant Korean women. Clin Chem Lab Med. 51(12):2295–301. DOI: 10.1515/cclm-2013-0598. PMID: 23979124.

26. Kim HJ, Cho YY, Kim SW, Kim TH, Jang HW, Lee SY, et al. 2018; Reference intervals of thyroid hormones during pregnancy in Korea, an iodine-replete area. Korean J Intern Med. 33(3):552–60. DOI: 10.3904/kjim.2016.051. PMID: 28171716. PMCID: PMC5943647.

27. Moon HW, Chung HJ, Park CM, Hur M, Yun YM. 2015; Establishment of trimester-specific reference intervals for thyroid hormones in Korean pregnant women. Ann Lab Med. 35(2):198–204. DOI: 10.3343/alm.2015.35.2.198. PMID: 25729721. PMCID: PMC4330169.

28. Maraka S, Mwangi R, McCoy RG, Yao X, Sangaralingham LR, Singh Ospina NM, et al. 2017; Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment. BMJ. 356:i6865. DOI: 10.1136/bmj.i6865. PMID: 28122781. PMCID: PMC5266622.

29. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Minooee S, Rahmati M, et al. 2018; Effects of levothyroxine on pregnant women with subclinical hypothyroidism, negative for thyroid peroxidase antibodies. J Clin Endocrinol Metab. 103(3):926–35. DOI: 10.1210/jc.2017-01850. PMID: 29126290.

30. Toft AD, Backett GJ. Braverman LE, Utiger RD, editors. 2005. Measuring serum thyrotropin and thyroid hormone and assessing thyroid hormone transport. Werner & Ingbar's the thyroid: a fundamental and clinical text. 9th ed. Lippincott, Williams & Wilkins;Philadelphia, PA: p. 329–44.

31. Anckaert E, Poppe K, Van Uytfanghe K, Schiettecatte J, Foulon W, Thienpont LM. FT4 immunoassays may display a pattern during pregnancy similar to the equilibrium dialysis ID-LC/tandem MS candidate reference measurement procedure in spite of susceptibility towards binding protein alterations. Clin Chim Acta. 2010; 411(17-18):1348–53. DOI: 10.1016/j.cca.2010.05.032. PMID: 20510682.

32. Lee RH, Spencer CA, Mestman JH, Miller EA, Petrovic I, Braverman LE, et al. 2009; Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol. 200(3):260 e1-6. DOI: 10.1016/j.ajog.2008.10.042. PMID: 19114271.

33. Stockigt J. 2003; Assessment of thyroid function: towards an integrated laboratory--clinical approach. Clin Biochem Rev. 24(4):109–22.

34. Thienpont LM, Van Uytfanghe K, Beastall G, Faix JD, Ieiri T, Miller WG, et al. 2010; Report of the IFCC Working Group for standardization of thyroid function tests; part 2: free thyroxine and free triiodothyronine. Clin Chem. 56(6):912–20. DOI: 10.1373/clinchem.2009.140194. PMID: 20395623.

35. Moreno-Reyes R, Glinoer D, Van Oyen H, Vandevijvere S. 2013; High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country: a population-based study. J Clin Endocrinol Metab. 98(9):3694–701. DOI: 10.1210/jc.2013-2149. PMID: 23846819.

36. Ashoor G, Maiz N, Rotas M, Kametas NA, Nicolaides KH. 2010; Maternal thyroid function at 11 to 13 weeks of gestation and subsequent development of preeclampsia. Prenat Diagn. 30(11):1032–8. DOI: 10.1002/pd.2566. PMID: 20865794.

37. Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TG, van der Wal MF, Bonsel GJ. 2007; Ethnic differences in TSH but not in free T4 concentrations or TPO antibodies during pregnancy. Clin Endocrinol (Oxf). 66(6):765–70. DOI: 10.1111/j.1365-2265.2007.02803.x. PMID: 17466012.

38. La'ulu SL, Roberts WL. 2007; Second-trimester reference intervals for thyroid tests: the role of ethnicity. Clin Chem. 53(9):1658–64. DOI: 10.1373/clinchem.2007.089680. PMID: 17712003.

39. Abbassi-Ghanavati M, Casey BM, Spong CY, McIntire DD, Halvorson LM, Cunningham FG. 2010; Pregnancy outcomes in women with thyroid peroxidase antibodies. Obstet Gynecol. 116(2 Pt 1):381–6. DOI: 10.1097/AOG.0b013e3181e904e5. PMID: 20664399.

40. Wasserman EE, Nelson K, Rose NR, Eaton W, Pillion JP, Seaberg E, et al. 2008; Maternal thyroid autoantibodies during the third trimester and hearing deficits in children: an epidemiologic assessment. Am J Epidemiol. 167(6):701–10. DOI: 10.1093/aje/kwm342. PMID: 18156602.

41. Pearce EN, Oken E, Gillman MW, Lee SL, Magnani B, Platek D, et al. 2008; Association of first-trimester thyroid function test values with thyroperoxidase antibody status, smoking, and multivitamin use. Endocr Pract. 14(1):33–9. DOI: 10.4158/EP.14.1.33. PMID: 18238739. PMCID: PMC2581507.

42. Moleti M, Lo Presti VP, Mattina F, Mancuso A, De Vivo A, Giorgianni G, et al. 2009; Gestational thyroid function abnormalities in conditions of mild iodine deficiency: early screening versus continuous monitoring of maternal thyroid status. Eur J Endocrinol. 160(4):611–7. DOI: 10.1530/EJE-08-0709. PMID: 19179457.

43. McElduff A, Morris J. 2008; Thyroid function tests and thyroid autoantibodies in an unselected population of women undergoing first trimester screening for aneuploidy. Aust N Z J Obstet Gynaecol. 48(5):478–80. DOI: 10.1111/j.1479-828X.2008.00903.x. PMID: 19032663.

44. Unuane D, Velkeniers B, Anckaert E, Schiettecatte J, Tournaye H, Haentjens P, et al. 2013; Thyroglobulin autoantibodies: is there any added value in the detection of thyroid autoimmunity in women consulting for fertility treatment? Thyroid. 23(8):1022–8. DOI: 10.1089/thy.2012.0562. PMID: 23405888. PMCID: PMC3752510.

45. Glinoer D, Riahi M, Grun JP, Kinthaert J. 1994; Risk of subclinical hypothyroidism in pregnant women with asymptomatic auto-immune thyroid disorders. J Clin Endocrinol Metab. 79(1):197–204. DOI: 10.1210/jcem.79.1.8027226. PMID: 8027226.

46. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. 2006; Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab. 91(7):2587–91. DOI: 10.1210/jc.2005-1603. PMID: 16621910.

47. Seror J, Amand G, Guibourdenche J, Ceccaldi PF, Luton D. 2014; Anti-TPO antibodies diffusion through the placental barrier during pregnancy. PLoS One. 9(1):e84647. DOI: 10.1371/journal.pone.0084647. PMID: 24497920. PMCID: PMC3908862.

48. Duntas LH, Mantzou E, Koutras DA. 2003; Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur J Endocrinol. 148(4):389–93. DOI: 10.1530/eje.0.1480389. PMID: 12656658.

49. Gartner R, Gasnier BC, Dietrich JW, Krebs B, Angstwurm MW. 2002; Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab. 87(4):1687–91. DOI: 10.1210/jcem.87.4.8421. PMID: 11932302.

50. Mazokopakis EE, Papadakis JA, Papadomanolaki MG, Batistakis AG, Giannakopoulos TG, Protopapadakis EE, et al. 2007; Effects of 12 months treatment with L-selenomethionine on serum anti-TPO Levels in Patients with Hashimoto's thyroiditis. Thyroid. 17(7):609–12. DOI: 10.1089/thy.2007.0040. PMID: 17696828.

51. Fan Y, Xu S, Zhang H, Cao W, Wang K, Chen G, et al. 2014; Selenium supplementation for autoimmune thyroiditis: a systematic review and meta-analysis. Int J Endocrinol. 2014:904573. DOI: 10.1155/2014/904573. PMID: 25574167. PMCID: PMC4276677.

52. Karanikas G, Schuetz M, Kontur S, Duan H, Kommata S, Schoen R, et al. 2008; No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid. 18(1):7–12. DOI: 10.1089/thy.2007.0127. PMID: 18302514.

53. Negro R, Greco G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. 2007; The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab. 92(4):1263–8. DOI: 10.1210/jc.2006-1821. PMID: 17284630.

54. Mao J, Pop VJ, Bath SC, Vader HL, Redman CW, Rayman MP. 2016; Effect of low-dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild-to-moderate iodine deficiency. Eur J Nutr. 55(1):55–61. DOI: 10.1007/s00394-014-0822-9. PMID: 25524327. PMCID: PMC4737786.

55. Mantovani G, Isidori AM, Moretti C, Di Dato C, Greco E, Ciolli P, et al. 2019; Selenium supplementation in the management of thyroid autoimmunity during pregnancy: results of the "SERENA study", a randomized, double-blind, placebo-controlled trial. Endocrine. 66(3):542–50. DOI: 10.1007/s12020-019-01958-1. PMID: 31129812.

56. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF, et al. 2007; Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 147(4):217–23. DOI: 10.7326/0003-4819-147-4-200708210-00175. PMID: 17620655.

57. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. 1988; Incidence of early loss of pregnancy. N Engl J Med. 319(4):189–94. DOI: 10.1056/NEJM198807283190401. PMID: 3393170.

58. Ellish NJ, Saboda K, O'Connor J, Nasca PC, Stanek EJ, Boyle C. 1996; A prospective study of early pregnancy loss. Hum Reprod. 11(2):406–12. DOI: 10.1093/HUMREP/11.2.406. PMID: 8671233.

59. Toth B, Jeschke U, Rogenhofer N, Scholz C, Wurfel W, Thaler CJ, et al. 2010; Recurrent miscarriage: current concepts in diagnosis and treatment. J Reprod Immunol. 85(1):25–32. DOI: 10.1016/j.jri.2009.12.006. PMID: 20185181.

60. Dudley DJ. 2007; Diabetic-associated stillbirth: incidence, pathophysiology, and prevention. Clin Perinatol. 34(4):611–26. viiDOI: 10.1016/j.clp.2007.09.003. PMID: 18063109.

61. De Vivo A, Mancuso A, Giacobbe A, Moleti M, Maggio Savasta L, De Dominici R, et al. 2010; Thyroid function in women found to have early pregnancy loss. Thyroid. 20(6):633–7. DOI: 10.1089/thy.2009.0323. PMID: 20470201.

62. Casey BM, Dashe JS, Wells CE, McIntire DD, Leveno KJ, Cunningham FG. 2006; Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol. 107(2 Pt 1):337–41. DOI: 10.1097/01.AOG.0000197991.64246.9a. PMID: 16449121.

63. Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Alvarez-Marfany M, Davies TF. 1990; Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA. 264(11):1422–5. DOI: 10.1001/jama.1990.03450110068029. PMID: 2118190.

64. Iijima T, Tada H, Hidaka Y, Mitsuda N, Murata Y, Amino N. 1997; Effects of autoantibodies on the course of pregnancy and fetal growth. Obstet Gynecol. 90(3):364–9. DOI: 10.1016/S0029-7844(97)00283-4. PMID: 9277645.

65. Glinoer D, Soto MF, Bourdoux P, Lejeune B, Delange F, Lemone M, et al. 1991; Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab. 73(2):421–7. DOI: 10.1210/jcem-73-2-421. PMID: 1906897.

66. Sezer K, Kamel N, Unlu C, Celik HK. 2009; Impact of first trimester and postpartum period thyroid autoantibodies on abortus incidence in Turkish pregnant women. Gynecol Endocrinol. 25(6):387–91. DOI: 10.1080/09513590902730812. PMID: 19903030.

67. Chen L, Hu R. 2011; Thyroid autoimmunity and miscarriage: a meta-analysis. Clin Endocrinol (Oxf). 74(4):513–9. DOI: 10.1111/j.1365-2265.2010.03974.x. PMID: 21198746.

68. Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A. 2011; Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ. 342:d2616. DOI: 10.1136/bmj.d2616. PMID: 21558126. PMCID: PMC3089879.

69. Seungdamrong A, Steiner AZ, Gracia CR, Legro RS, Diamond MP, Coutifaris C, et al. 2017; Preconceptional antithyroid peroxidase antibodies, but not thyroid-stimulating hormone, are associated with decreased live birth rates in infertile women. Fertil Steril. 108(5):843–850. DOI: 10.1016/j.fertnstert.2017.08.026. PMID: 29102040. PMCID: PMC8129952.

70. Imaizumi M, Pritsker A, Kita M, Ahmad L, Unger P, Davies T. 2001; Pregnancy and murine thyroiditis: thyroglobulin immunization leads to fetal loss in specific allogeneic pregnancies. Endocrinology. 142(2):823–9. DOI: 10.1210/endo.142.2.7966. PMID: 11159855.

71. Lee YL, Ng HP, Lau KS, Liu WM, O WS, Yeung WS, et al. 2009; Increased fetal abortion rate in autoimmune thyroid disease is related to circulating TPO autoantibodies in an autoimmune thyroiditis animal model. Fertil Steril. 91(5 Suppl):2104–9. DOI: 10.1016/j.fertnstert.2008.07.1704. PMID: 18774556.

72. Matalon ST, Blank M, Levy Y, Carp HJ, Arad A, Burek L, et al. 2003; The pathogenic role of anti-thyroglobulin antibody on pregnancy: evidence from an active immunization model in mice. Hum Reprod. 18(5):1094–9. DOI: 10.1093/humrep/deg210. PMID: 12721190.

73. Twig G, Shina A, Amital H, Shoenfeld Y. Pathogenesis of infertility and recurrent pregnancy loss in thyroid autoimmunity. J Autoimmun. 2012; 38(2-3):J275–81. DOI: 10.1016/j.jaut.2011.11.014. PMID: 22218218.

74. Lee RM, Silver RM. 2000; Recurrent pregnancy loss: summary and clinical recommendations. Semin Reprod Med. 18(4):433–40. DOI: 10.1055/s-2000-13733. PMID: 11355802.

75. Baek KH, Lee EJ, Kim YS. 2007; Recurrent pregnancy loss: the key potential mechanisms. Trends Mol Med. 13(7):310–7. DOI: 10.1016/j.molmed.2007.05.005. PMID: 17574920.

76. Iravani AT, Saeedi MM, Pakravesh J, Hamidi S, Abbasi M. 2008; Thyroid autoimmunity and recurrent spontaneous abortion in Iran: a case-control study. Endocr Pract. 14(4):458–64. DOI: 10.4158/EP.14.4.458. PMID: 18558600.

77. Kutteh WH, Yetman DL, Carr AC, Beck LA, Scott RT Jr. 1999; Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril. 71(5):843–8. DOI: 10.1016/S0015-0282(99)00091-6. PMID: 10231043.

78. Lata K, Dutta P, Sridhar S, Rohilla M, Srinivasan A, Prashad GR, et al. 2013; Thyroid autoimmunity and obstetric outcomes in women with recurrent miscarriage: a case-control study. Endocr Connect. 2(2):118–24. DOI: 10.1530/EC-13-0012. PMID: 23802061. PMCID: PMC3691574.

79. Pratt DE, Kaberlein G, Dudkiewicz A, Karande V, Gleicher N. 1993; The association of antithyroid antibodies in euthyroid nonpregnant women with recurrent first trimester abortions in the next pregnancy. Fertil Steril. 60(6):1001–5. DOI: 10.1016/S0015-0282(16)56400-0. PMID: 8243677.

80. Bliddal S, Feldt-Rasmussen U, Rasmussen AK, Kolte AM, Hilsted LM, Christiansen OB, et al. 2019; Thyroid peroxidase antibodies and prospective live birth rate: a cohort study of women with recurrent pregnancy loss. Thyroid. 29(10):1465–74. DOI: 10.1089/thy.2019.0077. PMID: 31407629.

81. van den Boogaard E, Vissenberg R, Land JA, van Wely M, van der Post JA, Goddijn M, et al. 2011; Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update. 17(5):605–19. DOI: 10.1093/humupd/dmr024. PMID: 21622978.

82. Dong AC, Morgan J, Kane M, Stagnaro-Green A, Stephenson MD. 2020; Subclinical hypothyroidism and thyroid autoimmunity in recurrent pregnancy loss: a systematic review and meta-analysis. Fertil Steril. 113(3):587–600 e1. DOI: 10.1016/j.fertnstert.2019.11.003. PMID: 32192591.

83. Esplin MS, Branch DW, Silver R, Stagnaro-Green A. 1998; Thyroid autoantibodies are not associated with recurrent pregnancy loss. Am J Obstet Gynecol. 179(6 Pt 1):1583–6. DOI: 10.1016/S0002-9378(98)70029-8. PMID: 9855601.

84. Rushworth FH, Backos M, Rai R, Chilcott IT, Baxter N, Regan L. 2000; Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum Reprod. 15(7):1637–9. DOI: 10.1093/humrep/15.7.1637. PMID: 10875881.

85. De Carolis C, Greco E, Guarino MD, Perricone C, Dal Lago A, Giacomelli R, et al. 2004; Anti-thyroid antibodies and antiphospholipid syndrome: evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters. Am J Reprod Immunol. 52(4):263–6. DOI: 10.1111/j.1600-0897.2004.00215.x. PMID: 15494047.

86. Kim NY, Cho HJ, Kim HY, Yang KM, Ahn HK, Thornton S, et al. 2011; Thyroid autoimmunity and its association with cellular and humoral immunity in women with reproductive failures. Am J Reprod Immunol. 65(1):78–87. DOI: 10.1111/j.1600-0897.2010.00911.x. PMID: 20712806.

87. Lepoutre T, Debieve F, Gruson D, Daumerie C. 2012; Reduction of miscarriages through universal screening and treatment of thyroid autoimmune diseases. Gynecol Obstet Invest. 74(4):265–73. DOI: 10.1159/000343759. PMID: 23147711.

88. Wang H, Gao H, Chi H, Zeng L, Xiao W, Wang Y, et al. 2017; Effect of levothyroxine on miscarriage among women with normal thyroid function and thyroid autoimmunity undergoing in vitro fertilization and embryo transfer: a randomized clinical trial. JAMA. 318(22):2190–8. DOI: 10.1001/jama.2017.18249. PMID: 29234808.

89. Dhillon-Smith RK, Middleton LJ, Sunner KK, Cheed V, Baker K, Farrell-Carver S, et al. 2019; Levothyroxine in women with thyroid peroxidase antibodies before conception. N Engl J Med. 380(14):1316–25. DOI: 10.1056/NEJMoa1812537. PMID: 30907987.

90. van Dijk MM, Vissenberg R, Fliers E, van der Post JAM, van der Hoorn MP, de Weerd S, et al. 2022; Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 10(5):322–9. DOI: 10.1016/S2213-8587(22)00045-6. PMID: 35298917.

91. Negro R, Schwartz A, Stagnaro-Green A. 2016; Impact of levothyroxine in miscarriage and preterm delivery rates in first trimester thyroid antibody-positive women with TSH less than 2.5 mIU/L. J Clin Endocrinol Metab. 101(10):3685–90. DOI: 10.1210/jc.2016-1803. PMID: 27459527.

92. Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Alavi Majd H, Azizi F. 2017; Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease. Eur J Endocrinol. 176(2):253–65. DOI: 10.1530/EJE-16-0548. PMID: 27879326.

93. Lau L, Benham JL, Lemieux P, Yamamoto J, Donovan LE. 2021; Impact of levothyroxine in women with positive thyroid antibodies on pregnancy outcomes: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 11(2):e043751. DOI: 10.1136/bmjopen-2020-043751. PMID: 33622947. PMCID: PMC7907864.

94. Mathews TJ, Menacker F, MacDorman MF. Centers for Disease Control and Prevention, National Center for Health Statistics. 2004; Infant mortality statistics from the 2002 period: linked birth/infant death data set. Natl Vital Stat Rep. 53(10):1–29. DOI: 10.1037/e558952006-001.

95. Petrou S. 2005; The economic consequences of preterm birth during the first 10 years of life. BJOG. 112 Suppl 1:10–5. DOI: 10.1111/j.1471-0528.2005.00577.x. PMID: 15715587.

96. Goldenberg RL, Culhane JF, Iams JD, Romero R. 2008; Epidemiology and causes of preterm birth. Lancet. 371(9606):75–84. DOI: 10.1016/S0140-6736(08)60074-4. PMID: 18177778.

97. Ghafoor F, Mansoor M, Malik T, Malik MS, Khan AU, Edwards R, et al. 2006; Role of thyroid peroxidase antibodies in the outcome of pregnancy. J Coll Physicians Surg Pak. 16(7):468–71.

98. Haddow JE, Cleary-Goldman J, McClain MR, Palomaki GE, Neveux LM, Lambert-Messerlian G, et al. 2010; Thyroperoxidase and thyroglobulin antibodies in early pregnancy and preterm delivery. Obstet Gynecol. 116(1):58–62. DOI: 10.1097/AOG.0b013e3181e10b30. PMID: 20567168.

99. Korevaar TI, Schalekamp-Timmermans S, de Rijke YB, Visser WE, Visser W, de Muinck Keizer-Schrama SM, et al. 2013; Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study. J Clin Endocrinol Metab. 98(11):4382–90. DOI: 10.1210/jc.2013-2855. PMID: 24037884.

100. Mannisto T, Vaarasmaki M, Pouta A, Hartikainen AL, Ruokonen A, Surcel HM, et al. 2009; Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study. J Clin Endocrinol Metab. 94(3):772–9. DOI: 10.1210/jc.2008-1520. PMID: 19106271.

101. Plowden TC, Schisterman EF, Sjaarda LA, Perkins NJ, Silver R, Radin R, et al. 2017; Thyroid-stimulating hormone, anti-thyroid antibodies, and pregnancy outcomes. Am J Obstet Gynecol. 217(6):697 e1-e7. DOI: 10.1016/j.ajog.2017.09.001. PMID: 28917612. PMCID: PMC5712235.

102. Negro R. 2011; Thyroid autoimmunity and pre-term delivery: brief review and meta-analysis. J Endocrinol Invest. 34(2):155–8. DOI: 10.1007/BF03347047. PMID: 21422804.

103. He X, Wang P, Wang Z, He X, Xu D, Wang B. 2012; Thyroid antibodies and risk of preterm delivery: a meta-analysis of prospective cohort studies. Eur J Endocrinol. 167(4):455–64. DOI: 10.1530/EJE-12-0379. PMID: 22826476.

104. Korevaar TIM, Pop VJ, Chaker L, Goddijn M, de Rijke YB, Bisschop PH, et al. 2018; Dose dependency and a functional cutoff for TPO-antibody positivity during pregnancy. J Clin Endocrinol Metab. 103(2):778–89. DOI: 10.1210/jc.2017-01560. PMID: 29240902.

105. Karakosta P, Alegakis D, Georgiou V, Roumeliotaki T, Fthenou E, Vassilaki M, et al. 2012; Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. J Clin Endocrinol Metab. 97(12):4464–72. DOI: 10.1210/jc.2012-2540. PMID: 23015651.

106. Kumru P, Erdogdu E, Arisoy R, Demirci O, Ozkoral A, Ardic C, et al. 2015; Effect of thyroid dysfunction and autoimmunity on pregnancy outcomes in low risk population. Arch Gynecol Obstet. 291(5):1047–54. DOI: 10.1007/s00404-014-3533-9. PMID: 25388918.

107. Han Y, Mao LJ, Ge X, Huang K, Yan SQ, Ren LL, et al. 2018; Impact of maternal thyroid autoantibodies positivity on the risk of early term birth: Ma'anshan birth cohort study. Endocrine. 60(2):329–38. DOI: 10.1007/s12020-018-1576-6. PMID: 29569122.

108. Korevaar TIM, Derakhshan A, Taylor PN, Meima M, Chen L, et al. Consortium on Thyroid and Pregnancy-Study Group on Preterm Birth. 2019; Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: a systematic review and meta-analysis. JAMA. 322(7):632–41. DOI: 10.1001/jama.2019.10931. PMID: 31429897. PMCID: PMC6704759.

109. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. 2011; Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes. J Clin Endocrinol Metab. 96(6):E920–4. DOI: 10.1210/jc.2011-0026. PMID: 21411559.

110. Groer MW, Vaughan JH. 2013; Positive thyroid peroxidase antibody titer is associated with dysphoric moods during pregnancy and postpartum. J Obstet Gynecol Neonatal Nurs. 42(1):E26–32. DOI: 10.1111/j.1552-6909.2012.01425.x. PMID: 23167615. PMCID: PMC3546200.

111. Kuijpens JL, Vader HL, Drexhage HA, Wiersinga WM, van Son MJ, Pop VJ. 2001; Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum. Eur J Endocrinol. 145(5):579–84. DOI: 10.1530/eje.0.1450579. PMID: 11720875.

112. Li Y, Shan Z, Teng W, Yu X, Li Y, Fan C, et al. 2010; Abnormalities of maternal thyroid function during pregnancy affect neuropsychological development of their children at 25-30 months. Clin Endocrinol (Oxf). 72(6):825–9. DOI: 10.1111/j.1365-2265.2009.03743.x. PMID: 19878506.

113. Williams FL, Watson J, Ogston SA, Visser TJ, Hume R, Willatts P. 2013; Maternal and umbilical cord levels of T4, FT4, TSH, TPOAb, and TgAb in term infants and neurodevelopmental outcome at 5.5 years. J Clin Endocrinol Metab. 98(2):829–38. DOI: 10.1210/jc.2012-3572. PMID: 23322817.

114. Wasserman EE, Pillion JP, Duggan A, Nelson K, Rohde C, Seaberg EC, et al. 2012; Childhood IQ, hearing loss, and maternal thyroid autoimmunity in the Baltimore collaborative perinatal project. Pediatr Res. 72(5):525–30. DOI: 10.1038/pr.2012.117. PMID: 22918523.

115. Derakhshan A, Korevaar TIM, Taylor PN, Levie D, Guxens M, Jaddoe VWV, et al. 2018; The association of maternal thyroid autoimmunity during pregnancy with Child IQ. J Clin Endocrinol Metab. 103(10):3729–36. DOI: 10.1210/jc.2018-00743. PMID: 30020468.

116. Ghassabian A, Bongers-Schokking JJ, de Rijke YB, van Mil N, Jaddoe VW, de Muinck Keizer-Schrama SM, et al. 2012; Maternal thyroid autoimmunity during pregnancy and the risk of attention deficit/hyperactivity problems in children: the generation R Study. Thyroid. 22(2):178–86. DOI: 10.1089/thy.2011.0318. PMID: 22175242. PMCID: PMC3271370.

117. Brown AS, Surcel HM, Hinkka-Yli-Salomaki S, Cheslack-Postava K, Bao Y, Sourander A. 2015; Maternal thyroid autoanti-body and elevated risk of autism in a national birth cohort. Prog Neuropsychopharmacol Biol Psychiatry. 57:86–92. DOI: 10.1016/j.pnpbp.2014.10.010. PMID: 25445476. PMCID: PMC4276336.

118. Heikkinen AL, Pakkila F, Hartikainen AL, Vaarasmaki M, Mannisto T, Suvanto E. 2017; Maternal thyroid antibodies associates with cardiometabolic risk factors in children at the age of 16. J Clin Endocrinol Metab. 102(11):4184–90. DOI: 10.1210/jc.2017-01137. PMID: 28945847.

119. Kent NL, Young SL, Akison LK, Cuffe JSM. 2021; Is the link between elevated TSH and gestational diabetes mellitus dependant on diagnostic criteria and thyroid antibody status: a systematic review and meta-analysis. Endocrine. 74(1):38–49. DOI: 10.1007/s12020-021-02733-x. PMID: 33991314.

120. Yang Y, Hou Y, Wang H, Gao X, Wang X, Li J, et al. 2020; Maternal thyroid dysfunction and gestational anemia risk: meta-analysis and new data. Front Endocrinol (Lausanne). 11:201. DOI: 10.3389/fendo.2020.00201. PMID: 32351449. PMCID: PMC7174567.

121. Krassas GE, Pontikides N, Kaltsas T, Papadopoulou P, Batrinos M. 1994; Menstrual disturbances in thyrotoxicosis. Clin Endocrinol (Oxf). 40(5):641–4. DOI: 10.1111/j.1365-2265.1994.tb03016.x. PMID: 8013145.

122. Krassas GE, Pontikides N, Kaltsas T, Papadopoulou P, Paunkovic J, Paunkovic N, et al. 1999; Disturbances of menstruation in hypothyroidism. Clin Endocrinol (Oxf). 50(5):655–9. DOI: 10.1046/j.1365-2265.1999.00719.x. PMID: 10468932.

123. Poppe K, Glinoer D, Van Steirteghem A, Tournaye H, Devroey P, Schiettecatte J, et al. 2002; Thyroid dysfunction and autoimmunity in infertile women. Thyroid. 12(11):997–1001. DOI: 10.1089/105072502320908330. PMID: 12490077.

124. Grassi G, Balsamo A, Ansaldi C, Balbo A, Massobrio M, Benedetto C. 2001; Thyroid autoimmunity and infertility. Gynecol Endocrinol. 15(5):389–96. DOI: 10.1080/gye.15.5.389.396. PMID: 11727362.

125. Quintino-Moro A, Zantut-Wittmann DE, Tambascia M, Machado Hda C, Fernandes A. 2014; High prevalence of infertility among women with Graves' disease and Hashimoto's thyroiditis. Int J Endocrinol. 2014:982705. DOI: 10.1155/2014/982705. PMID: 24678319. PMCID: PMC3942334.

126. Kucukler FK, Gorkem U, Simsek Y, Kocabas R, Guler S. 2018; Evaluation of ovarian reserve in women with overt or subclinical hypothyroidism. Arch Med Sci. 14(3):521–6. DOI: 10.5114/aoms.2016.58621. PMID: 29765437. PMCID: PMC5949893.

127. Lincoln SR, Ke RW, Kutteh WH. 1999; Screening for hypothyroidism in infertile women. J Reprod Med. 44(5):455–7.

128. Abalovich M, Mitelberg L, Allami C, Gutierrez S, Alcaraz G, Otero P, et al. 2007; Subclinical hypothyroidism and thyroid autoimmunity in women with infertility. Gynecol Endocrinol. 23(5):279–83. DOI: 10.1080/09513590701259542. PMID: 17558686.

129. Arojoki M, Jokimaa V, Juuti A, Koskinen P, Irjala K, Anttila L. 2000; Hypothyroidism among infertile women in Finland. Gynecol Endocrinol. 14(2):127–31. DOI: 10.3109/09513590009167671. PMID: 10836200.

130. Rao M, Wang H, Zhao S, Liu J, Wen Y, Wu Z, et al. 2020; Subclinical hypothyroidism is associated with lower ovarian reserve in women aged 35 years or older. Thyroid. 30(1):95–105. DOI: 10.1089/thy.2019.0031. PMID: 31650898.

131. Birjandi B, Ramezani Tehrani F, Amouzegar A, Tohidi M, Bidhendi Yarandi R, Azizi F. 2021; The association between subclinical hypothyroidism and TPOAb positivity with infertility in a population-based study: Tehran thyroid study (TTS). BMC Endocr Disord. 21(1):108. DOI: 10.1186/s12902-021-00773-y. PMID: 34034716. PMCID: PMC8152029.

132. Verma I, Sood R, Juneja S, Kaur S. 2012; Prevalence of hypothyroidism in infertile women and evaluation of response of treatment for hypothyroidism on infertility. Int J Appl Basic Med Res. 2(1):17–9. DOI: 10.4103/2229-516X.96795. PMID: 23776802. PMCID: PMC3657979.

133. Yoshioka W, Amino N, Ide A, Kang S, Kudo T, Nishihara E, et al. 2015; Thyroxine treatment may be useful for subclinical hypothyroidism in patients with female infertility. Endocr J. 62(1):87–92. DOI: 10.1507/endocrj.EJ14-0300. PMID: 25312747.

134. Monteleone P, Parrini D, Faviana P, Carletti E, Casarosa E, Uccelli A, et al. 2011; Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis. Am J Reprod Immunol. 66(2):108–14. DOI: 10.1111/j.1600-0897.2010.00961.x. PMID: 21241400.

135. Ott J, Aust S, Kurz C, Nouri K, Wirth S, Huber JC, et al. 2010; Elevated antithyroid peroxidase antibodies indicating Hashimoto's thyroiditis are associated with the treatment response in infertile women with polycystic ovary syndrome. Fertil Steril. 94(7):2895–7. DOI: 10.1016/j.fertnstert.2010.05.063. PMID: 20638057.

136. Karmon AE, Batsis M, Chavarro JE, Souter I. 2015; Preconcep-tional thyroid-stimulating hormone levels and outcomes of intrauterine insemination among euthyroid infertile women. Fertil Steril. 103(1):258–63 e1. DOI: 10.1016/j.fertnstert.2014.09.035. PMID: 25439842.

137. Pekcan MK, Ozgu-Erdinc AS, Yilmaz N. 2019; Impact of subclinical hypothyroidism and thyroid autoimmunity on clinical pregnancy rate after intrauterine insemination in euthyroid women. JBRA Assist Reprod. 23(2):137–42. DOI: 10.5935/1518-0557.20190027. PMID: 30951274. PMCID: PMC6501743.

138. Fumarola A, Grani G, Romanzi D, Del Sordo M, Bianchini M, Aragona A, et al. 2013; Thyroid function in infertile patients undergoing assisted reproduction. Am J Reprod Immunol. 70(4):336–41. DOI: 10.1111/aji.12113. PMID: 23521347.

139. Baker VL, Rone HM, Pasta DJ, Nelson HP, Gvakharia M, Adamson GD. 2006; Correlation of thyroid stimulating hormone (TSH) level with pregnancy outcome in women undergoing in vitro fertilization. Am J Obstet Gynecol. 194(6):1668–74. discussion 74–5. DOI: 10.1016/j.ajog.2006.03.040. PMID: 16731084.

140. Reh A, Grifo J, Danoff A. 2010; What is a normal thyroid-stimulating hormone (TSH) level? Effects of stricter TSH thresholds on pregnancy outcomes after in vitro fertilization. Fertil Steril. 94(7):2920–2. DOI: 10.1016/j.fertnstert.2010.06.041. PMID: 20655528.

141. Weghofer A, Himaya E, Kushnir VA, Barad DH, Gleicher N. 2015; The impact of thyroid function and thyroid autoimmunity on embryo quality in women with low functional ovarian reserve: a case-control study. Reprod Biol Endocrinol. 13:43. DOI: 10.1186/s12958-015-0041-0. PMID: 25975563. PMCID: PMC4443631.

142. Aghahosseini M, Asgharifard H, Aleyasin A, Tehrani Banihashemi A. 2014; Effects of thyroid stimulating hormone (TSH) level on clinical pregnancy rate via in vitro fertilization (IVF) procedure. Med J Islam Repub Iran. 28:46.

143. Green KA, Werner MD, Franasiak JM, Juneau CR, Hong KH, Scott RT Jr. 2015; Investigating the optimal preconception TSH range for patients undergoing IVF when controlling for embryo quality. J Assist Reprod Genet. 32(10):1469–76. DOI: 10.1007/s10815-015-0549-4. PMID: 26280527. PMCID: PMC4615921.

144. So S, Yamaguchi W, Murabayashi N, Miyano N, Tawara F. 2020; Effect of moderately increased thyroid-stimulating hormone levels and presence of thyroid antibodies on pregnancy among infertile women. Reprod Med Biol. 19(1):82–8. DOI: 10.1002/rmb2.12306. PMID: 31956289. PMCID: PMC6955587.

145. Karakis LS, Kiyak H, Okmen B, Ozdemir C, Turkgeldi E. 2021; Impact of preconceptional serum thyroid stimulating hormone values ranging between 2.5 and 4.5 mIU/L on live birth rates following ovulation induction and intrauterine insemination treatment for unexplained infertility. BMC Womens Health. 21(1):162. DOI: 10.1186/s12905-021-01299-0. PMID: 33874925. PMCID: PMC8056662.

146. Chai J, Yeung WY, Lee CY, Li HW, Ho PC, Ng HY. 2014; Live birth rates following in vitro fertilization in women with thyroid autoimmunity and/or subclinical hypothyroidism. Clin Endocrinol (Oxf). 80(1):122–7. DOI: 10.1111/cen.12220. PMID: 23566068.

147. Abdel Rahman AH, Aly Abbassy H, Abbassy AA. 2010; Improved in vitro fertilization outcomes after treatment of subclinical hypothyroidism in infertile women. Endocr Pract. 16(5):792–7. DOI: 10.4158/EP09365.OR. PMID: 20350920.

148. Kim CH, Ahn JW, Kang SP, Kim SH, Chae HD, Kang BM. 2011; Effect of levothyroxine treatment on in vitro fertilization and pregnancy outcome in infertile women with subclinical hypothyroidism undergoing in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 95(5):1650–4. DOI: 10.1016/j.fertnstert.2010.12.004. PMID: 21193190.

149. Velkeniers B, Van Meerhaeghe A, Poppe K, Unuane D, Tournaye H, Haentjens P. 2013; Levothyroxine treatment and pregnancy outcome in women with subclinical hypothyroidism undergoing assisted reproduction technologies: systematic review and meta-analysis of RCTs. Hum Reprod Update. 19(3):251–8. DOI: 10.1093/humupd/dms052. PMID: 23327883.

150. Arora H, Collazo I, Palmerola KL, Parmar M, Narasimman M, Hendon N, et al. 2022; Positive effects of thyroid replacement therapy on assisted reproductive technology outcomes in women with subclinical hypothyroidism with positive thyroid peroxidase autoantibodies. F S Rep. 3(1):32–8. DOI: 10.1016/j.xfre.2021.11.006. PMID: 35386496. PMCID: PMC8978068.

151. Jatzko B, Vytiska-Bistorfer E, Pawlik A, Promberger R, Mayerhofer K, Ott J. 2014; The impact of thyroid function on intrauterine insemination outcome--a retrospective analysis. Reprod Biol Endocrinol. 12:28. DOI: 10.1186/1477-7827-12-28. PMID: 24708845. PMCID: PMC3978130.

152. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, et al. 2017; 2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 27(3):315–89. DOI: 10.1089/thy.2016.0457. PMID: 28056690.

153. Poppe K, Bisschop P, Fugazzola L, Minziori G, Unuane D, Weghofer A. 2021; 2021 European Thyroid Association guideline on thyroid disorders prior to and during assisted reproduction. Eur Thyroid J. 9(6):281–95. DOI: 10.1159/000512790. PMID: 33718252. PMCID: PMC7923920.

154. Scoccia B, Demir H, Kang Y, Fierro MA, Winston NJ. 2012; In vitro fertilization pregnancy rates in levothyroxine-treated women with hypothyroidism compared to women without thyroid dysfunction disorders. Thyroid. 22(6):631–6. DOI: 10.1089/thy.2011.0343. PMID: 22540326. PMCID: PMC3412578.

155. Busnelli A, Somigliana E, Benaglia L, Leonardi M, Ragni G, Fedele L. 2013; In vitro fertilization outcomes in treated hypothyroidism. Thyroid. 23(10):1319–25. DOI: 10.1089/thy.2013.0044. PMID: 23544891.

156. Pelliccione F, Lania A, Pizzocaro A, Cafaro L, Negri L, Morenghi E, et al. 2018; Levothyroxine supplementation on assisted reproduction technology (ART) outcomes in women with subtle hypothyroidism: a retrospective study. Gynecol Endocrinol. 34(12):1053–8. DOI: 10.1080/09513590.2018.1499087. PMID: 30129807.

157. Zhong YP, Ying Y, Wu HT, Zhou CQ, Xu YW, Wang Q, et al. 2012; Relationship between antithyroid antibody and pregnancy outcome following in vitro fertilization and embryo transfer. Int J Med Sci. 9(2):121–5. DOI: 10.7150/ijms.3467. PMID: 22253557. PMCID: PMC3258552.

158. Tan S, Dieterle S, Pechlavanis S, Janssen OE, Fuhrer D. 2014; Thyroid autoantibodies per se do not impair intracytoplasmic sperm injection outcome in euthyroid healthy women. Eur J Endocrinol. 170(4):495–500. DOI: 10.1530/EJE-13-0790. PMID: 24394727.

159. Lukaszuk K, Kunicki M, Kulwikowska P, Liss J, Pastuszek E, Jaszczolt M, et al. 2015; The impact of the presence of antithyroid antibodies on pregnancy outcome following intracytoplasmatic sperm injection-ICSI and embryo transfer in women with normal thyreotropine levels. J Endocrinol Invest. 38(12):1335–43. DOI: 10.1007/s40618-015-0377-5. PMID: 26280321.

160. Karacan M, Alwaeely F, Cebi Z, Berberoglugil M, Batukan M, Ulug M, et al. 2013; Effect of antithyroid antibodies on ICSI outcome in antiphospholipid antibody-negative euthyroid women. Reprod Biomed Online. 27(4):376–80. DOI: 10.1016/j.rbmo.2013.07.002. PMID: 23953066.

161. Toulis KA, Goulis DG, Venetis CA, Kolibianakis EM, Negro R, Tarlatzis BC, et al. 2010; Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing IVF: a meta-analysis. Eur J Endocrinol. 162(4):643–52. DOI: 10.1530/EJE-09-0850. PMID: 19955261.

162. Inagaki Y, Takeshima K, Nishi M, Ariyasu H, Doi A, Kurimoto C, et al. 2020; The influence of thyroid autoimmunity on pregnancy outcome in infertile women: a prospective study. Endocr J. 67(8):859–68. DOI: 10.1507/endocrj.EJ19-0604. PMID: 32336697.

163. Negro R, Mangieri T, Coppola L, Presicce G, Casavola EC, Gismondi R, et al. 2005; Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study. Hum Reprod. 20(6):1529–33. DOI: 10.1093/humrep/deh843. PMID: 15878930.

164. Revelli A, Casano S, Piane LD, Grassi G, Gennarelli G, Guidetti D, et al. 2009; A retrospective study on IVF outcome in euthyroid patients with anti-thyroid antibodies: effects of levothyroxine, acetyl-salicylic acid and prednisolone adjuvant treatments. Reprod Biol Endocrinol. 7:137. DOI: 10.1186/1477-7827-7-137. PMID: 19941670. PMCID: PMC2788572.

165. Poppe K, Unuane D, D'Haeseleer M, Tournaye H, Schiettecatte J, Haentjens P, et al. 2011; Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome. Fertil Steril. 96(1):241–5. DOI: 10.1016/j.fertnstert.2011.04.039. PMID: 21565336.

166. Poppe K, Glinoer D, Tournaye H, Schiettecatte J, Devroey P, van Steirteghem A, et al. 2004; Impact of ovarian hyperstimu-lation on thyroid function in women with and without thyroid autoimmunity. J Clin Endocrinol Metab. 89(8):3808–12. DOI: 10.1210/jc.2004-0105. PMID: 15292309.

167. Mintziori G, Goulis DG, Toulis KA, Venetis CA, Kolibianakis EM, Tarlatzis BC. 2011; Thyroid function during ovarian stimulation: a systematic review. Fertil Steril. 96(3):780–5. DOI: 10.1016/j.fertnstert.2011.06.020. PMID: 21742326.

168. Muller AF, Verhoeff A, Mantel MJ, De Jong FH, Berghout A. 2000; Decrease of free thyroxine levels after controlled ovarian hyperstimulation. J Clin Endocrinol Metab. 85(2):545–8. DOI: 10.1210/jc.85.2.545. PMID: 10690853.

169. Poppe K, Glinoer D, Tournaye H, Schiettecatte J, Haentjens P, Velkeniers B. 2005; Thyroid function after assisted reproductive technology in women free of thyroid disease. Fertil Steril. 83(6):1753–7. DOI: 10.1016/j.fertnstert.2004.12.036. PMID: 15950647.

170. Gracia CR, Morse CB, Chan G, Schilling S, Prewitt M, Sammel MD, et al. 2012; Thyroid function during controlled ovarian hyperstimulation as part of in vitro fertilization. Fertil Steril. 97(3):585–91. DOI: 10.1016/j.fertnstert.2011.12.023. PMID: 22260853. PMCID: PMC3477594.

171. Reinblatt S, Herrero B, Correa JA, Shalom-Paz E, Ata B, Wiser A, et al. 2013; Thyroid stimulating hormone levels rise after assisted reproductive technology. J Assist Reprod Genet. 30(10):1347–52. DOI: 10.1007/s10815-013-0081-3. PMID: 23955685. PMCID: PMC3824851.

172. Benaglia L, Busnelli A, Somigliana E, Leonardi M, Vannucchi G, De Leo S, et al. 2014; Incidence of elevation of serum thyroid-stimulating hormone during controlled ovarian hyper-stimulation for in vitro fertilization. Eur J Obstet Gynecol Reprod Biol. 173:53–7. DOI: 10.1016/j.ejogrb.2013.11.003. PMID: 24332278.

173. Busnelli A, Somigliana E, Benaglia L, Sarais V, Ragni G, Fedele L. 2014; Thyroid axis dysregulation during in vitro fertilization in hypothyroid-treated patients. Thyroid. 24(11):1650–5. DOI: 10.1089/thy.2014.0088. PMID: 25089619.

174. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, et al. 1999; Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 341(8):549–55. DOI: 10.1056/NEJM199908193410801. PMID: 10451459.

175. van den Boogaard E, Vissenberg R, Land JA, van Wely M, Ven der Post JA, Goddijn M, et al. 2016; Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update. 22(4):532–3. DOI: 10.1093/humupd/dmw003. PMID: 26906092.

176. Turunen S, Vaarasmaki M, Marttila R, Leinonen MK, Gissler M, Mannisto T, et al. 2022; Indications for intensive care unit treatment among neonates born to mothers with thyroid disease: a population-based cohort study. Acta Obstet Gynecol Scand. 101(10):1093–101. DOI: 10.1111/aogs.14413. PMID: 35778835. PMCID: PMC9812201.

177. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. 2002; Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 12(1):63–8. DOI: 10.1089/105072502753451986. PMID: 11838732.

178. Leung AS, Millar LK, Koonings PP, Montoro M, Mestman JH. 1993; Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol. 81(3):349–53. DOI: 10.1016/0020-7292(93)90343-U. PMID: 8437784.

179. Allan WC, Haddow JE, Palomaki GE, Williams JR, Mitchell ML, Hermos RJ, et al. 2000; Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen. 7(3):127–30. DOI: 10.1136/jms.7.3.127. PMID: 11126160.

180. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. 2010; Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab. 95(4):1699–707. DOI: 10.1210/jc.2009-2009. PMID: 20130074.

181. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. 2010; Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab. 95(9):E44–8. DOI: 10.1210/jc.2010-0340. PMID: 20534758.

182. Casey BM, Dashe JS, Wells CE, McIntire DD, Byrd W, Leveno KJ, et al. 2005; Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol. 105(2):239–45. DOI: 10.1097/01.AOG.0000152345.99421.22. PMID: 15684146.

183. Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TG, Bonsel GJ. 2009; Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol. 160(6):985–91. DOI: 10.1530/EJE-08-0953. PMID: 19273570.

184. Ashoor G, Maiz N, Rotas M, Jawdat F, Nicolaides KH. 2010; Maternal thyroid function at 11 to 13 weeks of gestation and subsequent fetal death. Thyroid. 20(9):989–93. DOI: 10.1089/thy.2010.0058. PMID: 20718684.

185. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, Porter TF, et al. 2008; Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol. 112(1):85–92. DOI: 10.1097/AOG.0b013e3181788dd7. PMID: 18591312. PMCID: PMC4949950.

186. Mannisto T, Vaarasmaki M, Pouta A, Hartikainen AL, Ruokonen A, Surcel HM, et al. 2010; Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. J Clin Endocrinol Metab. 95(3):1084–94. DOI: 10.1210/jc.2009-1904. PMID: 20080846.

187. Medici M, Korevaar TI, Visser WE, Visser TJ, Peeters RP. 2015; Thyroid function in pregnancy: what is normal? Clin Chem. 61(5):704–13. DOI: 10.1373/clinchem.2014.236646. PMID: 25829408.

188. Toloza FJK, Derakhshan A, Mannisto T, Bliddal S, Popova PV, Carty DM, et al. 2022; Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis. Lancet Diabetes Endocrinol. 10(4):243–52. DOI: 10.1016/S2213-8587(22)00007-9. PMID: 35255260.

189. Wilson KL, Casey BM, McIntire DD, Halvorson LM, Cunningham FG. 2012; Subclinical thyroid disease and the incidence of hypertension in pregnancy. Obstet Gynecol. 119(2 Pt 1):315–20. DOI: 10.1097/AOG.0b013e318240de6a. PMID: 22270283.

190. Panagiotou G, Taylor PN, Rees DA, Okosieme OE. 2022; Late offspring effects of antenatal thyroid screening. Br Med Bull. 143(1):16–29. DOI: 10.1093/bmb/ldac018. PMID: 35868487.

191. Lazarus JH, Bestwick JP, Channon S, Paradice R, Maina A, Rees R, et al. 2012; Antenatal thyroid screening and childhood cognitive function. N Engl J Med. 366(6):493–501. DOI: 10.1056/NEJMoa1106104. PMID: 22316443. PMCID: PMC3814060.

192. Casey BM, Thom EA, Peaceman AM, Varner MW, Sorokin Y, Hirtz DG, et al. 2017; Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy. N Engl J Med. 376(9):815–25. DOI: 10.1056/NEJMoa1606205. PMID: 28249134. PMCID: PMC5605129.

193. Downing S, Halpern L, Carswell J, Brown RS. 2012; Severe maternal hypothyroidism corrected prior to the third trimester is associated with normal cognitive outcome in the offspring. Thyroid. 22(6):625–30. DOI: 10.1089/thy.2011.0257. PMID: 22574629.

194. Momotani N, Iwama S, Momotani K. 2012; Neurodevelopment in children born to hypothyroid mothers restored to normal thyroxine (T(4)) concentration by late pregnancy in Japan: no apparent influence of maternal T(4) deficiency. J Clin Endocrinol Metab. 97(4):1104–8. DOI: 10.1210/jc.2011-2797. PMID: 22319040.

195. Liu H, Momotani N, Noh JY, Ishikawa N, Takebe K, Ito K. 1994; Maternal hypothyroidism during early pregnancy and intellectual development of the progeny. Arch Intern Med. 154(7):785–7. DOI: 10.1001/archinte.1994.00420070109012. PMID: 8147683.

196. Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL, de Vijlder JJ. 2003; Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf). 59(3):282–8. DOI: 10.1046/j.1365-2265.2003.01822.x. PMID: 12919150.

197. Sahu MT, Das V, Mittal S, Agarwal A, Sahu M. 2010; Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet. 281(2):215–20. DOI: 10.1007/s00404-009-1105-1. PMID: 19437026.

198. Su PY, Huang K, Hao JH, Xu YQ, Yan SQ, Li T, et al. 2011; Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in China. J Clin Endocrinol Metab. 96(10):3234–41. DOI: 10.1210/jc.2011-0274. PMID: 21832110.

199. Henrichs J, Ghassabian A, Peeters RP, Tiemeier H. 2013; Maternal hypothyroxinemia and effects on cognitive functioning in childhood: how and why? Clin Endocrinol (Oxf). 79(2):152–62. DOI: 10.1111/cen.12227. PMID: 23600900.

200. Medici M, Timmermans S, Visser W, de Muinck Keizer-Schrama SM, Jaddoe VW, Hofman A, et al. 2013; Maternal thyroid hormone parameters during early pregnancy and birth weight: the generation R study. J Clin Endocrinol Metab. 98(1):59–66. DOI: 10.1210/jc.2012-2420. PMID: 23150694.

201. Nazarpour S, Ramezani Tehrani F, Rahmati M, Amiri M, Azizi F. 2022; Effects of isolated maternal hypothyroxinemia on adverse pregnancy outcomes. Arch Gynecol Obstet. 305(4):903–11. DOI: 10.1007/s00404-021-06226-0. PMID: 34482473.

202. Avramovska M, Karanfilski B, Dimitrov G, Dzikova E, Daneva Markova A, Hadzi Lega M, et al. 2021; Isolated maternal hypothyroxinemia and its perinatal outcome in North Macedonia. Acta Clin Croat. 60(2):246–53. DOI: 10.20471/acc.2021.60.02.10. PMID: 34744274. PMCID: PMC8564836.

203. Chen L, Yang H, Ye E, Lin Z, Peng M, Lin H, et al. 2020; Insignificant effect of isolated hypothyroxinemia on pregnancy outcomes during the first and second trimester of pregnancy. Front Endocrinol (Lausanne). 11:528146. DOI: 10.3389/fendo.2020.528146. PMID: 33178133. PMCID: PMC7596376.

204. Gong X, Liu A, Li Y, Sun H, Li Y, Li C, et al. 2019; The impact of isolated maternal hypothyroxinemia during the first and second trimester of gestation on pregnancy outcomes: an intervention and prospective cohort study in China. J Endocrinol Invest. 42(5):599–607. DOI: 10.1007/s40618-018-0960-7. PMID: 30334197. PMCID: PMC6476837.

205. Hamm MP, Cherry NM, Martin JW, Bamforth F, Burstyn I. 2009; The impact of isolated maternal hypothyroxinemia on perinatal morbidity. J Obstet Gynaecol Can. 31(11):1015–21. DOI: 10.1016/S1701-2163(16)34345-6. PMID: 20175339.

206. Casey BM, Dashe JS, Spong CY, McIntire DD, Leveno KJ, Cunningham GF. 2007; Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol. 109(5):1129–35. DOI: 10.1097/01.AOG.0000262054.03531.24. PMID: 17470594.

207. Turunen S, Vaarasmaki M, Mannisto T, Hartikainen AL, Lahesmaa-Korpinen AM, Gissler M, et al. 2019; Pregnancy and perinatal outcome among hypothyroid mothers: a population-based cohort study. Thyroid. 29(1):135–41. DOI: 10.1089/thy.2018.0311. PMID: 30417761.

208. Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. 2004; Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. 351(3):241–9. DOI: 10.1056/NEJMoa040079. PMID: 15254282.

209. Mandel SJ, Larsen PR, Seely EW, Brent GA. 1990; Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med. 323(2):91–6. DOI: 10.1056/NEJM199007123230204. PMID: 2359428.

210. Kaplan MM. 1992; Monitoring thyroxine treatment during pregnancy. Thyroid. 2(2):147–52. DOI: 10.1089/thy.1992.2.147. PMID: 1525583.

211. Loh JA, Wartofsky L, Jonklaas J, Burman KD. 2009; The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism. Thyroid. 19(3):269–75. DOI: 10.1089/thy.2008.0413. PMID: 19265498.

212. Yassa L, Marqusee E, Fawcett R, Alexander EK. 2010; Thyroid hormone early adjustment in pregnancy (the THERAPY) trial. J Clin Endocrinol Metab. 95(7):3234–41. DOI: 10.1210/jc.2010-0013. PMID: 20463094.

213. Rotondi M, Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Amato G, et al. 2004; Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy. Eur J Endocrinol. 151(6):695–700. DOI: 10.1530/eje.0.1510695. PMID: 15588235.

214. Abalovich M, Alcaraz G, Kleiman-Rubinsztein J, Pavlove MM, Cornelio C, Levalle O, et al. 2010; The relationship of preconception thyrotropin levels to requirements for increasing the levothyroxine dose during pregnancy in women with primary hypothyroidism. Thyroid. 20(10):1175–8. DOI: 10.1089/thy.2009.0457. PMID: 20860419.

215. Galofré JC, Haber RS, Mitchell AA, Pessah R, Davies TF. 2010; Increased postpartum thyroxine replacement in Hashimoto's thyroiditis. Thyroid. 20(8):901–8. DOI: 10.1089/thy.2009.0391.

216. Li N, Yang J, Chen X, Huang J, Lai M, Fang F, et al. 2020; Postpartum follow-up of patients with subclinical hypothyroidism during pregnancy. Thyroid. 30(11):1566–73. DOI: 10.1089/thy.2019.0714. PMID: 32375594.

217. Braverman LE, Utiger RD. Braverman LE, Utiger RD, editors. 2005. Introduction to thyrotoxicosis. Werner & Ingbar's the thyroid: a fundamental and clinical text. 9th ed. Lippincott, Williams & Wilkins;Philadelphia, PA: p. 453–5.

218. Cooper DS, Laurberg P. 2013; Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol. 1(3):238–49. DOI: 10.1016/S2213-8587(13)70086-X. PMID: 24622372.

219. Dong AC, Stagnaro-Green A. 2019; Differences in diagnostic criteria mask the true prevalence of thyroid disease in pregnancy: a systematic review and meta-analysis. Thyroid. 29(2):278–89. DOI: 10.1089/thy.2018.0475. PMID: 30444186.

220. Fan J, Zhang Y, Zhang C, Barjaktarovic M, Yang X, Peeters RP, et al. 2019; Persistency of thyroid dysfunction from early to late pregnancy. Thyroid. 29(10):1475–84. DOI: 10.1089/thy.2019.0115. PMID: 31347461.

221. Kinomoto-Kondo S, Umehara N, Sato S, Ogawa K, Fujiwara T, Arata N, et al. 2017; The effects of gestational transient thyrotoxicosis on the perinatal outcomes: a case-control study. Arch Gynecol Obstet. 295(1):87–93. DOI: 10.1007/s00404-016-4219-2. PMID: 27766407.

222. Fraenkel M, Shafat T, Cahn A, Erez O, Novack V, Tsur A. 2018; Low thyroid-stimulating hormone and its persistence beyond the first trimester of pregnancy. Int J Gynaecol Obstet. 142(3):270–6. DOI: 10.1002/ijgo.12540. PMID: 29856070.

223. Tan JY, Loh KC, Yeo GS, Chee YC. 2002; Transient hyperthyroidism of hyperemesis gravidarum. BJOG. 109(6):683–8. DOI: 10.1111/j.1471-0528.2002.01223.x. PMID: 12118648.

224. Niebyl JR. 2010; Clinical practice. Nausea and vomiting in pregnancy. N Engl J Med. 363(16):1544–50. DOI: 10.1056/NEJMcp1003896. PMID: 20942670.

225. Verberg MF, Gillott DJ, Al-Fardan N, Grudzinskas JG. 2005; Hyperemesis gravidarum, a literature review. Hum Reprod Update. 11(5):527–39. DOI: 10.1093/humupd/dmi021. PMID: 16006438.

226. Grun JP, Meuris S, De Nayer P, Glinoer D. 1997; The thyrotrophic role of human chorionic gonadotrophin (hCG) in the early stages of twin (versus single) pregnancies. Clin Endocrinol (Oxf). 46(6):719–25. DOI: 10.1046/j.1365-2265.1997.2011011.x. PMID: 9274703.

227. Hershman JM. 1999; Human chorionic gonadotropin and the thyroid: hyperemesis gravidarum and trophoblastic tumors. Thyroid. 9(7):653–7. DOI: 10.1089/thy.1999.9.653. PMID: 10447009.

228. Rodien P, Bremont C, Sanson ML, Parma J, Van Sande J, Costagliola S, et al. 1998; Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med. 339(25):1823–6. DOI: 10.1056/NEJM199812173392505. PMID: 9854118.

229. Goodwin TM, Montoro M, Mestman JH. 1992; Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol. 167(3):648–52. DOI: 10.1016/S0002-9378(11)91565-8. PMID: 1382389.

230. Bouillon R, Naesens M, Van Assche FA, De Keyser L, De Moor P, Renaer M, et al. 1982; Thyroid function in patients with hyperemesis gravidarum. Am J Obstet Gynecol. 143(8):922–6. DOI: 10.1016/0002-9378(82)90475-6. PMID: 7102767.

231. Laurberg P, Bournaud C, Karmisholt J, Orgiazzi J. 2009; Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol. 160(1):1–8. DOI: 10.1530/EJE-08-0663. PMID: 18849306.

232. de Jong JA, Verkooijen HM, Valk GD, Zelissen PM, de Keizer B. 2013; High failure rates after (131)I therapy in Graves hyperthyroidism patients with large thyroid volumes, high iodine uptake, and high iodine turnover. Clin Nucl Med. 38(6):401–6. DOI: 10.1097/RLU.0b013e3182817c78. PMID: 23579983.

233. Schneider DF, Sonderman PE, Jones MF, Ojomo KA, Chen H, Jaume JC, et al. 2014; Failure of radioactive iodine in the treatment of hyperthyroidism. Ann Surg Oncol. 21(13):4174–80. DOI: 10.1245/s10434-014-3858-4. PMID: 25001092. PMCID: PMC4330099.

234. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH. 1994; Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol. 84(6):946–9.

235. Papendieck P, Chiesa A, Prieto L, Gruneiro-Papendieck L. 2009; Thyroid disorders of neonates born to mothers with Graves' disease. J Pediatr Endocrinol Metab. 22(6):547–53. DOI: 10.1515/JPEM.2009.22.6.547. PMID: 19694202.

236. Phoojaroenchanachai M, Sriussadaporn S, Peerapatdit T, Vannasaeng S, Nitiyanant W, Boonnamsiri V, et al. 2001; Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clin Endocrinol (Oxf). 54(3):365–70. DOI: 10.1046/j.1365-2265.2001.01224.x. PMID: 11298089.

237. Sheffield JS, Cunningham FG. 2004; Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol. 190(1):211–7. DOI: 10.1016/S0002-9378(03)00944-X. PMID: 14749662.

238. Turunen S, Vaarasmaki M, Lahesmaa-Korpinen AM, Leinonen MK, Gissler M, Mannisto T, et al. 2020; Maternal hyperthyroidism and pregnancy outcomes: a population-based cohort study. Clin Endocrinol (Oxf). 93(6):721–8. DOI: 10.1111/cen.14282. PMID: 32657434.

239. Andersen SL, Andersen S, Vestergaard P, Olsen J. 2018; Maternal thyroid function in early pregnancy and child neurodevelopmental disorders: a Danish nationwide case-cohort study. Thyroid. 28(4):537–46. DOI: 10.1089/thy.2017.0425. PMID: 29584590.

240. Levie D, Korevaar TIM, Mulder TA, Bath SC, Dineva M, Lopez-Espinosa MJ, et al. 2019; Maternal thyroid function in early pregnancy and child attention-deficit hyperactivity disorder: an individual-participant meta-analysis. Thyroid. 29(9):1316–26. DOI: 10.1089/thy.2018.0794. PMID: 31426724.

241. Ge GM, Leung MTY, Man KKC, Leung WC, Ip P, Li GHY, et al. 2020; Maternal thyroid dysfunction during pregnancy and the risk of adverse outcomes in the offspring: a systematic review and meta-analysis. J Clin Endocrinol Metab. 105(12):dgaa555. DOI: 10.1210/clinem/dgaa555. PMID: 32810262.

242. Mandel SJ, Cooper DS. 2001; The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab. 86(6):2354–9. DOI: 10.1210/jcem.86.6.7573. PMID: 11397822.

243. Andersen SL, Olsen J, Laurberg P. 2016; Antithyroid drug side effects in the population and in pregnancy. J Clin Endocrinol Metab. 101(4):1606–14. DOI: 10.1210/jc.2015-4274. PMID: 26815881.

244. Bahn RS, Burch HS, Cooper DS, Garber JR, Greenlee CM, Klein IL, et al. 2009; The role of propylthiouracil in the management of Graves' disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid. 19(7):673–4. DOI: 10.1089/thy.2009.0169. PMID: 19583480.

245. Rivkees SA, Mattison DR. 2009; Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use. Int J Pediatr Endocrinol. 2009:132041. DOI: 10.1186/1687-9856-2009-132041.

246. Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT, Tenconi R. 1999; Methimazole embryopathy: delineation of the phenotype. Am J Med Genet. 83(1):43–6. DOI: 10.1002/(SICI)1096-8628(19990305)83:1<43::AID-AJMG8>3.0.CO;2-C.

247. Clementi M, Di Gianantonio E, Cassina M, Leoncini E, Botto LD, Mastroiacovo P, et al. 2010; Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab. 95(11):E337–41. DOI: 10.1210/jc.2010-0652. PMID: 20668039.

248. Barbero P, Valdez R, Rodriguez H, Tiscornia C, Mansilla E, Allons A, et al. 2008; Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study. Am J Med Genet A. 146A(18):2390–5. DOI: 10.1002/ajmg.a.32497. PMID: 18698631.

249. Andersen SL, Olsen J, Wu CS, Laurberg P. 2013; Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. J Clin Endocrinol Metab. 98(11):4373–81. DOI: 10.1210/jc.2013-2831. PMID: 24151287.

250. Seo GH, Kim TH, Chung JH. 2018; Antithyroid drugs and congenital malformations: a nationwide Korean cohort study. Ann Intern Med. 168(6):405–13. DOI: 10.7326/M17-1398. PMID: 29357398.

251. Miao Y, Xu Y, Teng P, Wang A, Zhang Y, Zhou Y, et al. 2022; Efficacy of propylthiouracil in the treatment of pregnancy with hyperthyroidism and its effect on pregnancy outcomes: a meta-analysis. PLoS One. 17(3):e0265085. DOI: 10.1371/journal.pone.0265085. PMID: 35271661. PMCID: PMC8912150.

252. Morales DR, Fonkwen L, Nordeng HME. 2021; Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations. Br J Clin Pharmacol. 87(10):3890–900. DOI: 10.1111/bcp.14805. PMID: 33783857.

253. Song R, Lin H, Chen Y, Zhang X, Feng W. 2017; Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: a meta-analysis. PLoS One. 12(7):e0180108. DOI: 10.1371/journal.pone.0180108. PMID: 28671971. PMCID: PMC5495385.

254. Yu W, Wu N, Li L, Wang J, OuYang H, Shen H. 2020; Side effects of PTU and MMI in the treatment of hyperthyroidism: a systematic review and meta-analysis. Endocr Pract. 26(2):207–17. DOI: 10.4158/EP-2019-0221. PMID: 31652102.

255. Laurberg P, Andersen SL. 2014; Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk? Eur J Endocrinol. 171(1):R13–20. DOI: 10.1530/EJE-14-0135. PMID: 24662319.

256. Andersen SL, Olsen J, Wu CS, Laurberg P. 2014; Severity of birth defects after propylthiouracil exposure in early pregnancy. Thyroid. 24(10):1533–40. DOI: 10.1089/thy.2014.0150. PMID: 24963758. PMCID: PMC4195247.

257. Laurberg P, Krejbjerg A, Andersen SL. 2014; Relapse following antithyroid drug therapy for Graves' hyperthyroidism. Curr Opin Endocrinol Diabetes Obes. 21(5):415–21. DOI: 10.1097/MED.0000000000000088. PMID: 25111942.

258. Cooper DS. 2003; Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies. J Clin Endocrinol Metab. 88(8):3474–81. DOI: 10.1210/jc.2003-030185. PMID: 12915620.

259. Rubin PC. 1981; Current concepts: beta-blockers in pregnancy. N Engl J Med. 305(22):1323–6. DOI: 10.1056/NEJM198111263052205. PMID: 6117014.

260. Sherif IH, Oyan WT, Bosairi S, Carrascal SM. 1991; Treatment of hyperthyroidism in pregnancy. Acta Obstet Gynecol Scand. 70(6):461–3. DOI: 10.3109/00016349109007160. PMID: 1763610.

261. Abraham P, Avenell A, McGeoch SC, Clark LF, Bevan JS. 2010; Antithyroid drug regimen for treating Graves' hyperthyroidism. Cochrane Database Syst Rev. 2010(1):CD003420. DOI: 10.1002/14651858.CD003420.pub4. PMID: 20091544. PMCID: PMC6599817.

262. Patil-Sisodia K, Mestman JH. 2010; Graves hyperthyroidism and pregnancy: a clinical update. Endocr Pract. 16(1):118–29. DOI: 10.4158/EP09233.RA. PMID: 19833580.

263. Ochoa-Maya MR, Frates MC, Lee-Parritz A, Seely EW. 1999; Resolution of fetal goiter after discontinuation of propylthiouracil in a pregnant woman with Graves' hyperthyroidism. Thyroid. 9(11):1111–4. DOI: 10.1089/thy.1999.9.1111. PMID: 10595460.

264. Hamburger JI. 1992; Diagnosis and management of Graves' disease in pregnancy. Thyroid. 2(3):219–24. DOI: 10.1089/thy.1992.2.219. PMID: 1422234.

265. Amino N, Tanizawa O, Mori H, Iwatani Y, Yamada T, Kurachi K, et al. 1982; Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. J Clin Endocrinol Metab. 55(1):108–12. DOI: 10.1210/jcem-55-1-108. PMID: 6896207.

266. Laurberg P, Nygaard B, Glinoer D, Grussendorf M, Orgiazzi J. 1998; Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol. 139(6):584–6. DOI: 10.1530/eje.0.1390584. PMID: 9916861.

267. Momotani N, Hisaoka T, Noh J, Ishikawa N, Ito K. 1992; Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy. J Clin Endocrinol Metab. 75(3):738–44. DOI: 10.1210/jcem.75.3.1517362. PMID: 1517362.

268. Zwaveling-Soonawala N, van Trotsenburg P, Vulsma T. 2009; Central hypothyroidism in an infant born to an adequately treated mother with Graves' disease: an effect of maternally derived thyrotrophin receptor antibodies? Thyroid. 19(6):661–2. DOI: 10.1089/thy.2008.0348. PMID: 19499992.

269. Kempers MJ, van Tijn DA, van Trotsenburg AS, de Vijlder JJ, Wiedijk BM, Vulsma T. 2003; Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. J Clin Endocrinol Metab. 88(12):5851–7. DOI: 10.1210/jc.2003-030665. PMID: 14671180.

270. Gruner C, Kollert A, Wildt L, Dorr HG, Beinder E, Lang N. 2001; Intrauterine treatment of fetal goitrous hypothyroidism controlled by determination of thyroid-stimulating hormone in fetal serum. A case report and review of the literature. Fetal Diagn Ther. 16(1):47–51. DOI: 10.1159/000053880. PMID: 11125252.

271. Peleg D, Cada S, Peleg A, Ben-Ami M. 2002; The relationship between maternal serum thyroid-stimulating immunoglobulin and fetal and neonatal thyrotoxicosis. Obstet Gynecol. 99(6):1040–3. DOI: 10.1097/00006250-200206000-00016. PMID: 12052596.

272. Luton D, Le Gac I, Vuillard E, Castanet M, Guibourdenche J, Noel M, et al. 2005; Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab. 90(11):6093–8. DOI: 10.1210/jc.2004-2555. PMID: 16118343.

273. Zimmerman D. 1999; Fetal and neonatal hyperthyroidism. Thyroid. 9(7):727–33. DOI: 10.1089/thy.1999.9.727. PMID: 10447021.

274. Yoshihara A, Iwaku K, Noh JY, Watanabe N, Kunii Y, Ohye H, et al. 2019; Incidence of neonatal hyperthyroidism among newborns of Graves' disease patients treated with radioiodine therapy. Thyroid. 29(1):128–34. DOI: 10.1089/thy.2018.0165. PMID: 30426886.

275. van Dijk MM, Smits IH, Fliers E, Bisschop PH. 2018; Maternal thyrotropin receptor antibody concentration and the risk of fetal and neonatal thyrotoxicosis: a systematic review. Thyroid. 28(2):257–64. DOI: 10.1089/thy.2017.0413. PMID: 29325496.

276. Rotondi M, Cappelli C, Pirali B, Pirola I, Magri F, Fonte R, et al. 2008; The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab. 93(10):3985–8. DOI: 10.1210/jc.2008-0966. PMID: 18664537.

277. Benhaim Rochester D, Davies TF. 2005; Increased risk of Graves' disease after pregnancy. Thyroid. 15(11):1287–90. DOI: 10.1089/thy.2005.15.1287. PMID: 16356094.

278. Rotondi M, Pirali B, Lodigiani S, Bray S, Leporati P, Chytiris S, et al. 2008; The post partum period and the onset of Graves' disease: an overestimated risk factor. Eur J Endocrinol. 159(2):161–5. DOI: 10.1530/EJE-08-0236. PMID: 18483014.

279. Amino N, Mori H, Iwatani Y, Tanizawa O, Kawashima M, Tsuge I, et al. 1982; High prevalence of transient post-partum thyrotoxicosis and hypothyroidism. N Engl J Med. 306(14):849–52. DOI: 10.1056/NEJM198204083061405. PMID: 7062963.

280. Qaseem A, Snow V, Owens DK, Shekelle P. Clinical Guidelines Committee of the American College of Physicians. 2010; The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann Intern Med. 153(3):194–9. DOI: 10.7326/0003-4819-153-3-201008030-00010. PMID: 20679562.

281. Stagnaro-Green A. 2012; Approach to the patient with postpartum thyroiditis. J Clin Endocrinol Metab. 97(2):334–42. DOI: 10.1210/jc.2011-2576. PMID: 22312089.

282. Stagnaro-Green A. 2002; Clinical review 152: postpartum thyroiditis. J Clin Endocrinol Metab. 87(9):4042–7. DOI: 10.1210/jc.2002-020524. PMID: 12213841.

283. Stagnaro-Green A, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Negro R. 2011; High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroiditis in Southern Italy. J Clin Endocrinol Metab. 96(3):652–7. DOI: 10.1210/jc.2010-1980. PMID: 21190974.

284. Benvenga S, Di Bari F, Vita R, Le Donne M, Triolo O, Granese R, et al. 2019; Relatively high rate of postpartum thyroiditis in the Straits of Messina area. Predictivity of both postpartum thyroiditis and permanent hypothyroidism by performing, in the first trimester of gestation, thyroid ultrasonography and measurement of serum thyroperoxidase and thyroglobulin autoantibodies. J Clin Transl Endocrinol. 15:12–8. DOI: 10.1016/j.jcte.2018.11.004. PMID: 30555788. PMCID: PMC6275208.

285. Muller AF, Drexhage HA, Berghout A. 2001; Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev. 22(5):605–30. DOI: 10.1210/edrv.22.5.0441. PMID: 11588143.

286. Kuijpens JL, De Hann-Meulman M, Vader HL, Pop VJ, Wiersinga WM, Drexhage HA. 1998; Cell-mediated immunity and postpartum thyroid dysfunction: a possibility for the prediction of disease? J Clin Endocrinol Metab. 83(6):1959–66. DOI: 10.1210/jcem.83.6.4838. PMID: 9626126.

287. Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Wallenstein S, Davies TF. 1992; A prospective study of lymphocyte-initiated immunosuppression in normal pregnancy: evidence of a T-cell etiology for postpartum thyroid dysfunction. J Clin Endocrinol Metab. 74(3):645–53. DOI: 10.1210/jcem.74.3.1740500. PMID: 1740500.

288. Smallridge RC. 2000; Postpartum thyroid disease. A model of immunologic dysfunction. Clin Appl Immunol Rev. 1:89–103. DOI: 10.1016/S1529-1049(00)00008-8.

289. Ide A, Amino N, Kang S, Yoshioka W, Kudo T, Nishihara E, et al. 2014; Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow. Thyroid. 24(6):1027–31. DOI: 10.1089/thy.2013.0585. PMID: 24400892.

290. Nicholson WK, Robinson KA, Smallridge RC, Ladenson PW, Powe NR. 2006; Prevalence of postpartum thyroid dysfunction: a quantitative review. Thyroid. 16(6):573–82. DOI: 10.1089/thy.2006.16.573. PMID: 16839259.

291. Gerstein HC. 1993; Incidence of postpartum thyroid dysfunction in patients with type I diabetes mellitus. Ann Intern Med. 118(6):419–23. DOI: 10.7326/0003-4819-118-6-199303150-00004. PMID: 8439115.

292. Alvarez-Marfany M, Roman SH, Drexler AJ, Robertson C, Stagnaro-Green A. 1994; Long-term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus. J Clin Endocrinol Metab. 79(1):10–6. DOI: 10.1210/jcem.79.1.8027213. PMID: 8027213.

293. Elefsiniotis IS, Vezali E, Pantazis KD, Saroglou G. 2008; Post-partum thyroiditis in women with chronic viral hepatitis. J Clin Virol. 41(4):318–9. DOI: 10.1016/j.jcv.2007.12.010. PMID: 18243783.

294. Stagnaro-Green A, Akhter E, Yim C, Davies TF, Magder L, Petri M. 2011; Thyroid disease in pregnant women with systemic lupus erythematosus: increased preterm delivery. Lupus. 20(7):690–9. DOI: 10.1177/0961203310394894. PMID: 21436215.

295. Tagami T, Hagiwara H, Kimura T, Usui T, Shimatsu A, Naruse M. 2007; The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease. Thyroid. 17(8):767–72. DOI: 10.1089/thy.2007.0003. PMID: 17651013.

296. Manetti L, Parkes AB, Lupi I, Di Cianni G, Bogazzi F, Albertini S, et al. 2008; Serum pituitary antibodies in normal pregnancy and in patients with postpartum thyroiditis: a nested case-control study. Eur J Endocrinol. 159(6):805–9. DOI: 10.1530/EJE-08-0617. PMID: 18787047.

297. Lazarus JH, Ammari F, Oretti R, Parkes AB, Richards CJ, Harris B. 1997; Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract. 47(418):305–8.

298. Caixas A, Albareda M, Garcia-Patterson A, Rodriguez-Espinosa J, de Leiva A, Corcoy R. 1999; Postpartum thyroiditis in women with hypothyroidism antedating pregnancy? J Clin Endocrinol Metab. 84(11):4000–5. DOI: 10.1210/jcem.84.11.6144. PMID: 10566640.

299. Marqusee E, Hill JA, Mandel SJ. 1997; Thyroiditis after pregnancy loss. J Clin Endocrinol Metab. 82(8):2455–7. DOI: 10.1210/jc.82.8.2455. PMID: 9253317.

300. Walfish PG, Meyerson J, Provias JP, Vargas MT, Papsin FR. 1992; Prevalence and characteristics of post-partum thyroid dysfunction: results of a survey from Toronto, Canada. J Endocrinol Invest. 15(4):265–72. DOI: 10.1007/BF03348726. PMID: 1512416.

301. Hayslip CC, Fein HG, O'Donnell VM, Friedman DS, Klein TA, Smallridge RC. 1988; The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction. Am J Obstet Gynecol. 159(1):203–9. DOI: 10.1016/0002-9378(88)90522-4. PMID: 3394739.

302. Lazarus JH. 1999; Clinical manifestations of postpartum thyroid disease. Thyroid. 9(7):685–9. DOI: 10.1089/thy.1999.9.685. PMID: 10447015.

303. Pop VJ, de Rooy HA, Vader HL, van der Heide D, van Son M, Komproe IH, et al. 1991; Postpartum thyroid dysfunction and depression in an unselected population. N Engl J Med. 324(25):1815–6. DOI: 10.1056/NEJM199106203242516. PMID: 2064682.

304. Le Donne M, Settineri S, Benvenga S. 2012; Early pospartum alexithymia and risk for depression: relationship with serum thyrotropin, free thyroid hormones and thyroid autoantibodies. Psychoneuroendocrinology. 37(4):519–33. DOI: 10.1016/j.psyneuen.2011.08.001. PMID: 22047958.

305. Bergink V, Pop VJM, Nielsen PR, Agerbo E, Munk-Olsen T, Liu X. 2018; Comorbidity of autoimmune thyroid disorders and psychiatric disorders during the postpartum period: a Danish nationwide register-based cohort study. Psychol Med. 48(8):1291–8. DOI: 10.1017/S0033291717002732. PMID: 28929982.

306. Lucas A, Pizarro E, Granada ML, Salinas I, Sanmarti A. 2001; Postpartum thyroid dysfunction and postpartum depression: are they two linked disorders? Clin Endocrinol (Oxf). 55(6):809–14. DOI: 10.1046/j.1365-2265.2001.01421.x. PMID: 11895224.

307. Pop VJ, de Rooy HA, Vader HL, van der Heide D, van Son MM, Komproe IH. 1993; Microsomal antibodies during gestation in relation to postpartum thyroid dysfunction and depression. Acta Endocrinol (Copenh). 129(1):26–30. DOI: 10.1530/acta.0.1290026. PMID: 8351955.

308. Harris B, Othman S, Davies JA, Weppner GJ, Richards CJ, Newcombe RG, et al. 1992; Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ. 305(6846):152–6. DOI: 10.1136/bmj.305.6846.152. PMID: 1515829. PMCID: PMC1883200.

309. Lazarus JH, Hall R, Othman S, Parkes AB, Richards CJ, McCulloch B, et al. 1996; The clinical spectrum of postpartum thyroid disease. QJM. 89(6):429–35. DOI: 10.1093/qjmed/89.6.429. PMID: 8758046.

310. Konstantakou P, Chalarakis N, Valsamakis G, Sakkas EG, Vousoura E, Gryparis A, et al. 2021; Associations of thyroid hormones profile during normal pregnancy and postpartum with anxiety, depression, and obsessive/compulsive disorder scores in euthyroid women. Front Neurosci. 15:663348. DOI: 10.3389/fnins.2021.663348. PMID: 34421508. PMCID: PMC8371251.

311. Wesseloo R, Kamperman AM, Bergink V, Pop VJM. 2018; Thyroid peroxidase antibodies during early gestation and the subsequent risk of first-onset postpartum depression: a prospective cohort study. J Affect Disord. 225:399–403. DOI: 10.1016/j.jad.2017.08.058. PMID: 28850854.

312. Minaldi E, D'Andrea S, Castellini C, Martorella A, Francavilla F, Francavilla S, et al. 2020; Thyroid autoimmunity and risk of post-partum depression: a systematic review and meta-analysis of longitudinal studies. J Endocrinol Invest. 43(3):271–7. DOI: 10.1007/s40618-019-01120-8. PMID: 31552596.

313. Harris B, Oretti R, Lazarus J, Parkes A, John R, Richards C, et al. 2002; Randomised trial of thyroxine to prevent postnatal depression in thyroid-antibody-positive women. Br J Psychiatry. 180:327–30. DOI: 10.1192/bjp.180.4.327. PMID: 11925355.

314. Costantine MM, Smith K, Thom EA, Casey BM, Peaceman AM, Varner MW, et al. 2020; Effect of thyroxine therapy on depressive symptoms among women with subclinical hypothyroidism. Obstet Gynecol. 135(4):812–20. DOI: 10.1097/AOG.0000000000003724. PMID: 32168208. PMCID: PMC7103482.

315. Fung HY, Kologlu M, Collison K, John R, Richards CJ, Hall R, et al. 1988; Postpartum thyroid dysfunction in Mid Glamorgan. Br Med J (Clin Res Ed). 296(6617):241–4. DOI: 10.1136/bmj.296.6617.241. PMID: 3124900. PMCID: PMC2544770.

316. Rasmussen NG, Hornnes PJ, Hoier-Madsen M, Feldt-Rasmussen U, Hegedus L. 1990; Thyroid size and function in healthy pregnant women with thyroid autoantibodies. Relation to development of postpartum thyroiditis. Acta Endocrinol (Copenh). 123(4):395–401. DOI: 10.1530/acta.0.1230395. PMID: 2239087.

317. Azizi F. 2005; The occurrence of permanent thyroid failure in patients with subclinical postpartum thyroiditis. Eur J Endocrinol. 153(3):367–71. DOI: 10.1530/eje.1.01976. PMID: 16131598.

318. Nohr SB, Jorgensen A, Pedersen KM, Laurberg P. 2000; Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody-positive women living in an area with mild to moderate iodine deficiency: is iodine supplementation safe? J Clin Endocrinol Metab. 85(9):3191–8. DOI: 10.1210/jcem.85.9.6799. PMID: 10999807.

319. Gao X, Wang X, Han Y, Wang H, Li J, Hou Y, et al. 2021; Postpartum thyroid dysfunction in women with known and newly diagnosed hypothyroidism in early pregnancy. Front Endocrinol (Lausanne). 12:746329. DOI: 10.3389/fendo.2021.746329. PMID: 34899598. PMCID: PMC8662309.

320. Kampe O, Jansson R, Karlsson FA. 1990; Effects of L-thyroxine and iodide on the development of autoimmune postpartum thyroiditis. J Clin Endocrinol Metab. 70(4):1014–8. DOI: 10.1210/jcem-70-4-1014. PMID: 2318931.

321. Eriksen KG, Andersson M, Hunziker S, Zimmermann MB, Moore SE. 2020; Effects of an iodine-containing prenatal multiple micronutrient on maternal and infant iodine status and thyroid function: a randomized trial in the Gambia. Thyroid. 30(9):1355–65. DOI: 10.1089/thy.2019.0789. PMID: 32183608. PMCID: PMC7482118.

322. Mridha MK, Matias SL, Paul RR, Hussain S, Khan MSA, Siddiqui Z, et al. 2017; Daily consumption of lipid-based nutrient supplements containing 250 mug iodine does not increase urinary iodine concentrations in pregnant and postpartum women in Bangladesh. J Nutr. 147(8):1586–92. DOI: 10.3945/jn.117.248963. PMID: 28615379.